EP12.01. Osteoblastic Bone Reaction in Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Treated with Osimertinib - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Kensuke Kanaoka
Meta Tag
Speaker Kensuke Kanaoka
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
osteoblastic bone reaction
non-small cell lung cancer
epidermal growth factor receptor
EGFR mutations
bone metastases
sclerotic bone lesions
lytic bone lesions
mixed bone lesions
Powered By